Gilteritinib for the Treatment of ALK NSCLC

Conditions: Lung Non-Small Cell Carcinoma; Stage IV Lung Cancer AJCC v8 Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Echocardiography; Drug: Gilteritinib; Procedure: Magnetic Resonance Imaging; Other: Questionnaire Administration Sponsors: University of Michigan Rogel Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials